Natures Sunshine Products Bolsa (NASDAQ: NATR)

Natures Sunshine Products (NASDAQ:NATR) Bolsa

Natures Sunshine Products

Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.

ALTG

Alterity Therapeutics Limited - American Depositary Shares

ATHE

CARM

CNCK

CRGX

FBNC

MGOL

NAOV

NATR

OFIX

RNGR

SLXN

TSLA

VREX

XFOR

Meta sube en la preapertura tras superar expectativas. Descubre qué otras acciones están registrando fuertes movimientos hoy.

Acciones de Meta Platforms (META) están cotizando al alza; 20 acciones que se mueven en el premercado de EE.UU.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ALVO

BBGI

BCAX

ELTX

FOXO

ISPC

JBHT

LYTS

MDXG

NUKK

TMCI

TXNM

VIAV

WILC

Explora los mayores ganadores y perdedores en las operaciones previas al mercado. Descubre qué impulsó estos movimientos destacados.

Las acciones de Versus Systems (VS) aumentan un 71%; 20 acciones que se mueven en el premercado de EE.UU.

Advanced Environmental Recycling Technologies

AERT

AILE

CTXR

HONE

HSON

INTZ

KORE

LITM

PDYN

REKR

SLDP

VINC

WATT

Descubre los mayores ganadores y perdedores en el mercado previo tras movimientos impactantes en acciones clave hoy.

Las acciones de Vincerx Pharma (VINC) suben alrededor del 64%; 20 acciones que se mueven en premercado

Nature's Sunshine Products, Inc. - Common Stock

Natures Sunshine Products Inc

Shares of Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) rose sharply in today's pre-market trading after the company reported better-than-expected <a href="https://www.benzinga.com/general/social-media/25/01/43322201/meta-platforms-q4-earnings-revenue-beat-eps-beat-daily-actives-up-5-continued-strong-revenue-growth-expected">fourth-quarter sales results</a>.
Meta reported fourth-quarter revenue of $48.39 billion, beating analyst estimates of $47.03 billion. The company reported fourth-quarter earnings of $8.02 per share, beating analyst estimates of $6.77 per share.
Meta shares gained 2.2% to $691.66 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Alterity Therapeutics Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATHE#NASDAQ">ATHE</a>) gained 105% to $6.13 in pre-market trading.</li>
<li>NanoVibronix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAOV#NASDAQ">NAOV</a>) rose 54.1% to $0.5853 in pre-market trading.</li>
<li>X4 Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XFOR#NASDAQ">XFOR</a>) gained 40.1% to $1.03 in pre-market trading after jumping more than 52% on Wednesday.</li>
<li>MGO Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGOL#NASDAQ">MGOL</a>) gained 21.9% to $0.1240 in pre-market trading after dipping over 38% on Wednesday.</li>
<li>Carisma Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARM#NASDAQ">CARM</a>) gained 18.4% to $0.5980 in pre-market trading.</li>
<li>Alta Equipment Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALTG#NYSE">ALTG</a>) rose 14.1% to $8.01 in pre-market trading.</li>
<li>Celestica Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) shares jumped 13.1% to $113.66 in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued FY25 guidance above estimates.</li>
<li>Ranger Energy Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNGR#NYSE">RNGR</a>) gained 10.5% to $19.00 in pre-market trading.</li>
<li>Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) rose 2.9% to $400.23 in pre-market trading. Tesla reported weaker-than-expected fourth-quarter earnings and sales results. The company, meanwhile, said it expects its vehicle business to return to growth in 2025. Tesla also promised to launch new and &#8220;more affordable&#8221; models in the first half of 2025, in addition to other promises regarding the deployment of autonomous vehicles and licensing of the company&#8217;s full self-driving (FSD) driver assistance software to rivals.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>CARGO Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRGX#NASDAQ">CRGX</a>) shares fell 74.3% to $3.39 in pre-market trading after the company announced it discontinued its FIRCE-1 Phase 2 study.</li>
<li>Nature&#8217;s Sunshine Products, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>) dipped 46.6% to $8.00 in pre-market trading.</li>
<li>Silexion Therapeutics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLXN#NASDAQ">SLXN</a>) shares fell 32.4% to $2.12 in pre-market trading. Silexion Therapeutics announced exercise of warrants for $3.3 million gross proceeds.</li>
<li>Avalon Holdings Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AWX#NYSE">AWX</a>) fell 19.2% to $2.90 in today's pre-market trading.</li>
<li>Coincheck Group N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNCK#NASDAQ">CNCK</a>) shares dipped 17.1% to $7.00 in pre-market trading after falling 4% on Wednesday.</li>
<li>Varex Imaging Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VREX#NASDAQ">VREX</a>) shares tumbled 12.2% to $11.94 in pre-market trading. Varex Imaging will report unaudited financial results for the first quarter of fiscal year 2025 following the close of regular trading on Thursday, Feb. 6.</li>
<li>Whirlpool Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WHR#NYSE">WHR</a>) fell 10.6% to $116.00 in pre-market trading after the company reported worse-than-expected fourth-quarter revenue results and issued FY25 guidance below estimates.</li>
<li>ServiceNow, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) fell 9.4% to $1,035.79 in pre-market trading after the company reported worse-than-expected quarterly revenue results.</li>
<li>Orthofix Medical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFIX#NASDAQ">OFIX</a>) declined 9.1% to $17.01 in pre-market trading. Orthofix Medical will release its fourth quarter and full-year 2024 financial results on Tuesday, Feb. 25, before the opening bell.</li>
<li>First Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBNC#NASDAQ">FBNC</a>) fell 6.8% to $41.00 in pre-market trading following fourth-quarter earnings.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43300989/jim-cramer-this-industrial-stock-is-absolutely-terrific-first-solar-is-very-inexpensive">Jim Cramer: This Industrial Stock Is &#8216;Absolutely Terrific&#8217;, First Solar Is &#8216;Very Inexpensive&#8217;</a></li>
</ul>

Why Meta Platforms Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Shares of Versus Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VS#NASDAQ">VS</a>) rose sharply in today's pre-market trading after the company announced expansion into the Brazilian market as part of its strategy to grow its <a href="https://www.benzinga.com/quote/VS/news">international footprint</a>.
Versus Systems shares jumped 71.2% to $3.39 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>iSpecimen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPC#NASDAQ">ISPC</a>) gained 49.1% to $4.25 in pre-market trading after the company announced it secured a supplier for hMPV biospecimens.</li>
<li>Nukkleus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUKK#NASDAQ">NUKK</a>) rose 33% to $27.30 in pre-market trading after the company announced it resolved its Nasdaq delisting notice and is now achieving compliance with the listing standards.</li>
<li>Signing Day Sports, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGN#NYSE">SGN</a>) rose 19.2% to $2.55 in pre-market trading after declining 9% on Thursday.</li>
<li>uCloudlink Group Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCL#NASDAQ">UCL</a>) gained 18.7% to $1.59 in pre-market trading. uCloudlink Group announced that it recently signed a cooperation agreement with WH Smith PLC&#8217;s InMotion Entertainment Group.</li>
<li>Treasure Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) gained 15.3% to $0.2471 in pre-market trading after gaining around 7% on Thursday.</li>
<li>TXNM Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TXNM#NYSE">TXNM</a>) gained 14.3% to $55.99 in pre-market trading.</li>
<li>Treace Medical Concepts, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMCI#NASDAQ">TMCI</a>) gained 14% to $9.40 in pre-market trading. On Monday, Treace announced preliminary, unaudited fourth quarter and full-year 2024 revenue.</li>
<li>LSI Industries Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYTS#NASDAQ">LYTS</a>) rose 8.8% to $21.00 in pre-market trading. LSI Industries will issue fiscal 2025 second quarter results before the opening bell on Thursday, Jan. 23, 2025.</li>
<li>Orthofix Medical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFIX#NASDAQ">OFIX</a>) gained 8.1% to $19.39 in pre-market trading.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Beasley Broadcast Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBGI#NASDAQ">BBGI</a>) fell 43.8% to $5.00 in pre-market trading.</li>
<li>Viavi Solutions Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIAV#NASDAQ">VIAV</a>) shares fell 19.3% to $8.10 in pre-market trading. Viavi Solutions will announce its fiscal second quarter 2025 financial results on Thursday, Jan. 30, 2025, after the close of market.</li>
<li>FOXO Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOXO#NYSE">FOXO</a>) fell 18.4% to $0.2566 in pre-market trading after gaining 58% on Thursday.</li>
<li>Nature&#8217;s Sunshine Products, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>) shares dipped 15.9% to $12.00 in pre-market trading.</li>
<li>Elicio Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTX#NASDAQ">ELTX</a>) shares tumbled 12.8% to $5.61 in pre-market trading.</li>
<li>G. Willi-Food International Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WILC#NASDAQ">WILC</a>) shares fell 11.5% to $14.01 in pre-market trading.</li>
<li>Bicara Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCAX#NASDAQ">BCAX</a>) fell 11.5% to $10.51 in today's pre-market trading after declining 8% on Thursday.</li>
<li>J.B. Hunt Transport Services, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>) declined 10.3% to $167.00 in pre-market trading as the company reported weaker-than-expected earnings for its fourth quarter on Thursday.</li>
<li>MiMedx Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDXG#NASDAQ">MDXG</a>) dipped 6.3% to $8.50 in pre-market trading.</li>
<li>Alvotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALVO#NASDAQ">ALVO</a>) fell 5% to $12.60 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43049593/slb-jb-hunt-transport-and-3-stocks-to-watch-heading-into-friday">SLB, J.B. Hunt Transport And 3 Stocks To Watch Heading Into Friday</a></li>
</ul>

Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket

Shares of Vincerx Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINC#NASDAQ">VINC</a>) rose sharply in today's pre-market trading after the company announced a binding term sheet for a strategic <a href="https://www.benzinga.com/quote/VINC/news">merger with Oqory, Inc</a>.
Vincerx Pharma shares jumped 63.9% to $0.3180 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Intrusion Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>) gained 120% to $4.76 in pre-market trading after surging around 380% on Friday.</li>
<li>Rekor Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REKR#NASDAQ">REKR</a>) gained 98.4% to $2.58 in pre-market trading after gaining 27% on Friday.</li>
<li>Energous Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WATT#NASDAQ">WATT</a>) rose 78.7% to $0.7237 in pre-market trading.</li>
<li>Castellum, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTM#NYSE">CTM</a>) gained 54.2% to $2.19 in pre-market trading after gaining 3% on Friday. Castellum announced the pricing of a previously announced stock offering of 4,355,000 shares at 85 cents per share for gross proceeds of approximately $3.7 million.</li>
<li>Solidion Technology Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STI#NASDAQ">STI</a>) gained 51.2% to $1.06 in pre-market trading after surging around 69% on Friday.</li>
<li>Aeries Technology, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AERT#NASDAQ">AERT</a>) gained 41.4% to $1.24 in pre-market trading after falling around 5% on Friday.</li>
<li>KORE Group Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KORE#NYSE">KORE</a>) rose 31.6% to $3.21 in pre-market trading after climbing around 28% on Friday.</li>
<li>Palladyne AI Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDYN#NASDAQ">PDYN</a>) gained 22.7% to $14.45 in pre-market trading after gaining over 61% on Friday.</li>
<li>Solid Power, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLDP#NASDAQ">SLDP</a>) gained 15% to $2.45 in pre-market trading after adding 9% on Friday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>CEL-SCI Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVM#NYSE">CVM</a>) fell 43.3% to $0.34 in pre-market trading as the company priced its $5 million public offering 16.13 million common shares at 31 cents per share.</li>
<li>Snow Lake Resources Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITM#NASDAQ">LITM</a>) shares tumbled 33.1% to $1.07 in pre-market trading after surging around 82% on Friday.</li>
<li>iLearningEngines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AILE#NASDAQ">AILE</a>) declined 27.5% to $0.43 in pre-market trading after jumping around 267% on Friday.</li>
<li>Citius Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTXR#NASDAQ">CTXR</a>) shares dipped 16.5% to $3.07 in pre-market trading. Citius Pharmaceuticals reported a net loss of $39.4 million, or $5.97 per share for the full year ended Sept. 30, versus a year-ago net loss of $32.5 million, or $5.57 per share.</li>
<li>Hudson Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSON#NASDAQ">HSON</a>) shares fell 15.5% to $11.31 in pre-market trading.</li>
<li>Tamboran Resources Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBN#NYSE">TBN</a>) fell 14.4% to $16.00 in pre-market trading.</li>
<li>Meiwu Technology Company Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WNW#NASDAQ">WNW</a>) shares fell 14.4% to $1.97 in pre-market trading after jumping 32% on Friday.</li>
<li>Nature&#8217;s Sunshine Products, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>) fell 13.4% to $13.01 in today's pre-market trading.</li>
<li>HarborOne Bancorp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HONE#NASDAQ">HONE</a>) dipped 11.5% to $10.60 in pre-market trading.</li>
<li>Sprott Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SII#NYSE">SII</a>) fell 6.4% to $39.31 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42700627/how-to-earn-500-a-month-from-rpm-international-stock-ahead-of-q2-earnings">How To Earn $500 A Month From RPM International Stock Ahead Of Q2 Earnings</a></li>
</ul>

Why Vincerx Pharma Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket

Natures Sunshine Products (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $0.14 by 92.86 percent. This is a 80 percent increase over earnings of $0.15 per share from the same period last year. The company reported quarterly sales of $114.615 million which beat the analyst consensus estimate of $108.946 million by 5.20 percent. This is a 3.07 percent increase over sales of $111.202 million the same period last year.

Earnings

Earnings Beats

Natures Sunshine Products Q3 2024 Adj. EPS $0.27 Beats $0.14 Estimate, Sales $114.615M Beat $108.946M Estimate

Natures Sunshine Products (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>) raises FY2024 sales outlook from $436.00 million-445.00 million to $443.00 million-448.00 million.

Guidance

Natures Sunshine Products Raises FY2024 Sales Guidance from $436.00M-445.00M to $443.00M-448.00M  VS Est. $439.16M

Canaccord Genuity analyst Susan Anderson initiated coverage on Nature&#8217;s Sunshine Products (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>) with a Buy rating <a target="_blank" href="https://www.benzinga.com/quote/NATR/analyst-ratings" rel="noreferrer noopener">and a price forecast of&nbsp;$18.</a>
The analyst highlights that the company&#8217;s products are distributed in over 40 countries, with Asia leading at 45% of sales, North America at 31%, Europe at 18%, and LATAM and other regions at 8% as of FY23.
According to the analyst, Nature&#8217;s Sunshine is poised for margin expansion as it increases sales through three key strategies: investing in the higher-margin, rapidly growing digital sector, expanding its international presence in critical markets, and driving innovation in a sector with rising consumer interest.
Anderson writes these initiatives should allow the company to reach the 15% adjusted EBITDA margin goals by FY28, up from ~9% in FY23.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/24/09/40859088/kkr-aims-to-replicate-european-private-equity-success-report" rel="noreferrer noopener">KKR Aims To Replicate European Private Equity Success: Report</a>
The analyst points out that, given the global shift towards greater health awareness post-pandemic, the company is well-positioned to capture a substantial share of the expanding market.
According to the analyst, the company&#8217;s gross margins could improve through greater product innovation, a shift towards higher-margin digital products, and relief from cost inflation and currency headwinds.
The analyst forecasts that if sales grow at a low-single-digit CAGR, management could enhance operating expenses by approximately 300 basis points.
Anderson projects FY24 adjusted EPS of $0.54, with net sales of $439.5 million.
Price Action: NATR shares are trading higher by 6.26% to $14.08 at last check Friday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/09/40858884/wall-street-aims-for-fifth-straight-gain-small-caps-soar-as-2-ye" target="_blank" rel="noreferrer noopener">Wall Street Aims For Fifth Straight Gain, Small Caps Soar As 2-Year Yields Hit 2-Year Lows, Adobe Sinks: What&#8217;s Driving Markets Friday?</a></li>
</ul>

Analyst Color

Equities

Price Target

Initiation

Analyst Ratings

General

Nature's Sunshine To Gain From Margin Expansion - Analyst Projects 15% Adjusted EBITDA Margin By FY28

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page.</a>
<ul>
<li>BMO Capital analyst Ameet Thakkar initiated coverage on GE Vernova Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) with an Outperform rating and announced a price target of $245. GE Vernova shares gained 2.9% to close at $215.27 on Thursday. See how other analysts view this stock.</li>
<li>Raymond James analyst Srini Pajjuri initiated coverage on Arm Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) with an Outperform rating and announced a price target of $160. ARM shares fell 0.8% to close at $139.18 on Thursday. See how other analysts view this stock.</li>
<li>Canaccord Genuity analyst Susan Anderson initiated coverage on Nature&#8217;s Sunshine Products, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>) with a Buy rating and announced a price target of $18. Natures Sunshine Products shares gained 1.2% to close at $13.25 on Thursday. See how other analysts view this stock.</li>
<li>CLSA initiated coverage on NuScale Power Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) with an Outperform rating and announced a price target of $11. NuScale Power shares fell 1.3% to close at $8.63 on Thursday. See how other analysts view this stock.</li>
<li>Jefferies analyst Paul Zimbardo initiated coverage on Public Service Enterprise Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEG#NYSE">PEG</a>) with a Hold rating and announced a price target of $85. Public Service Enterprise shares rose 1.4% to close at $83.31 on Thursday. See how other analysts view this stock.</li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/09/40850889/4m-bet-on-this-energy-stock-check-out-these-3-stocks-executives-are-buying">$4M Bet On This Energy Stock? Check Out These 3 Stocks Executives Are Buying</a></li>
</ul>

This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Canaccord Genuity analyst Susan Anderson initiates coverage on Natures Sunshine Products (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>) with a Buy rating and announces Price Target of $18.

Canaccord Genuity Initiates Coverage On Natures Sunshine Products with Buy Rating, Announces Price Target of $18

The facility was evacuated and local emergency services were called to the scene to help manage the incident. All personnel&nbsp;are&nbsp;safe and&nbsp;accounted for, and two&nbsp;individuals&nbsp;were seen by EMTs and released to leave the facility.
The company is working to determine the cause of the&nbsp;malfunction, which resulted in a small fire,&nbsp;and to assess the extent of the damage to the facility.&nbsp;
A portion of the facility will temporarily be closed for repairs while normal operations continue in unaffected areas.

Nature's Sunshine Says An Equipment Malfunction Occurred At Its Spanish Fork, Utah Manufacturing Facility Early Yesterday Morning

DA Davidson analyst Linda Bolton Weiser maintains Natures Sunshine Products (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>) with a Buy and lowers the price target from $23 to $21.

DA Davidson Maintains Buy on Natures Sunshine Products, Lowers Price Target to $21

WIIM

Nature's Sunshine Products shares are trading lower after the company reported worse-than-expected Q2 financial results and lowered FY24 net sales guidance.

Nature's Sunshine Products Sees FY24 Net Sales $436M-$445M (Prior $455M-$480M)

Natures Sunshine Products (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.25 by 72 percent. The company reported quarterly sales of $110.551 million which missed the analyst consensus estimate of $112.280 million by 1.54 percent. This is a 5.15 percent decrease over sales of $116.548 million the same period last year.

Earnings Misses

Natures Sunshine Products Q2 2024 Adj. EPS $0.07 Misses $0.25 Estimate, Sales $110.551M Miss $112.280M Estimate

Nature's Sunshine shares are trading lower after the company reported worse-than-expected Q1 financial results.

Natures Sunshine Products Sees FY24 Net Sales $455M-$480M Vs $467.900M Est.

Natures Sunshine Products (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>) reported quarterly earnings of $0.12 per share which missed the analyst consensus estimate of $0.17 by 29.41 percent. This is a 47.83 percent decrease over earnings of $0.23 per share from the same period last year. The company reported quarterly sales of $110.993 million which missed the analyst consensus estimate of $111.200 million by 0.19 percent. This is a 2.17 percent increase over sales of $108.634 million the same period last year.

Natures Sunshine Products Q1 2024 Adj EPS $0.12 Misses $0.17 Estimate, Sales $110.993M Miss $111.200M Estimate

Shares of Clover Health Investments, Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clov#NASDAQ">CLOV</a>) rose sharply during Wednesday&rsquo;s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24 insurance revenue guidance.
Clover Health Investments reported quarterly sales of $510.3 million which beat the analyst consensus estimate of $480.25 million by 6.26% and represents a 43.22% decrease over sales of $898.79 million the same period last year.
Clover Health Investments shares climbed 11.2% to $0.8537 on Wednesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Gaxos.ai Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gxai#NASDAQ">GXAI</a>) shares jumped 128.9% to $12.18 after the company announced it acquired the rights to use certain AI-enabled technology from Ultiself.</li>
<li>Veritone, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/veri#NASDAQ">VERI</a>) gained 52.4% to $2.6076 following strong sales results.</li>
<li>NuCana plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ncna#NASDAQ">NCNA</a>) gained 50.2% to $0.5869 after the company was granted a US Patent for &quot;Phosphoramidate Derivatives For Use In The Treatment Of Cancer; Especially In The Treatment Where The Patient Shows Resistance.&quot;</li>
<li>The Beauty Health Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/skin#NASDAQ">SKIN</a>) rose 31.9% to $4.7350 after the company reported better-than-expected fourth-quarter revenue results.</li>
<li>Arq, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arq#NASDAQ">ARQ</a>) gained 28.3% to $4.4522 after the company reported upbeat fourth-quarter results.</li>
<li>MicroCloud Hologram Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holo#NASDAQ">HOLO</a>) jumped 26.6% to $6.19.</li>
<li>Kintara Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ktra#NASDAQ">KTRA</a>) shares gained 26.2% to $0.1055.</li>
<li>Nature&#39;s Sunshine Products, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/natr#NASDAQ">NATR</a>) jumped 24.7% to $21.47 after the company reported better-than-expected fourth-quarter adjusted EPS results and issued FY24 net sales guidance.</li>
<li>Heron Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hrtx#NASDAQ">HRTX</a>) gained 24.7% to $2.9428 after the company reported better-than-expected fourth-quarter adjusted EPS results and issued FY24 revenue guidance. Also, Needham maintained a Buy rating on the stock and raised its price target from $4 to $5.</li>
<li>Li-Cycle Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/licy#NASDAQ">LICY</a>) shares gained 23.2% to $0.7233. Li-Cycle shares jumped 46% on Tuesday after the company entered an agreement to issue a senior secured convertible note in an aggregate principal amount of $75 million to an affiliate of Glencore.</li>
<li>Cue Biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cue#NASDAQ">CUE</a>) gained 19.2% to $2.11 after Jefferies initiated coverage on the stock with a Buy rating and $6 price target.</li>
<li>AdTheorent Holding Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adth#NASDAQ">ADTH</a>) surged 19% to $3.4150 following strong sales.</li>
<li>SIGA Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/siga#NASDAQ">SIGA</a>) gained 18.8% to $6.32 after the company reported a year-over-year increase in quarterly financial results.</li>
<li>Educational Development Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/educ#NASDAQ">EDUC</a>) surged 18.1% to $2.0432.</li>
<li>Portage Biotech Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prtg#NASDAQ">PRTG</a>) gained 17.7% to $0.6589.</li>
<li>Williams-Sonoma, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wsm#NYSE">WSM</a>) climbed 17.7% to $283.70 after the company reported better-than-expected fourth-quarter earnings, announced a new $ 1 billion stock repurchase authorization and increased its quarterly dividend.</li>
<li>HUTCHMED (China) Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcm#NASDAQ">HCM</a>) shares climbed 15.8% to $18.91 after gaining 9% on Tuesday.</li>
<li>Annexon, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/annx#NASDAQ">ANNX</a>) rose 15% to $5.28. Needham analyst Joseph Stringer reiterated Annexon with a Buy and maintained a $16 price target.</li>
<li>Mind Medicine (MindMed) Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnmd#NASDAQ">MNMD</a>) gained 13.2% to $8.90.</li>
<li>Full Truck Alliance Co. Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ymm#NYSE">YMM</a>) climbed 11.2% to $7.74. Full Truck Alliance announced extension of share repurchase program up to $300 million.</li>
<li>Summit Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smmt#NASDAQ">SMMT</a>) gained 10% to $4.7450.</li>
<li>Qilian International Holding Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qli#NASDAQ">QLI</a>) climbed 10% to $0.6052.</li>
<li>PBF Energy Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pbf#NYSE">PBF</a>) gained 9.4% to $55.18.</li>
<li>BeiGene, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bgne#NASDAQ">BGNE</a>) shares climbed 9% to $178.44.</li>
<li>Minim, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/minm#NASDAQ">MINM</a>) gained 8.3% to $5.43 after the company announced that it entered into a definitive merger agreement with e2Companies.</li>
<li>Recursion Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rxrx#NASDAQ">RXRX</a>) rose 7% to $ 11.27.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>voxeljet AG (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vjet#NASDAQ">VJET</a>) shares fell 40.8% to $0.5922 after the company announced it will voluntarily delist its ADSs from Nasdaq and deregister its ADSs. The company also announced the restatement and extension of its loan financing with Anzu.</li>
<li>Luna Innovations Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/luna#NASDAQ">LUNA</a>) fell 39% to $3.82 after the company announced that it will delay the release of its fourth-quarter and FY23 financial results. and said financial statements for the quarters ended Jun. 30 and Sept. 30 should no longer be relied upon.</li>
<li>SurgePays, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/surg#NASDAQ">SURG</a>) fell 30.5% to $4.86 after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>P3 Health Partners Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/piii#NASDAQ">PIII</a>) fell 29.4% to $0.72.</li>
<li>SOS Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sos#NYSE">SOS</a>) dipped 28% to $1.5399 G</li>
<li>Allbirds, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bird#NASDAQ">BIRD</a>) declined 25.3% to $0.6952 after the company reported worse-than-expected fourth-quarter GAAP EPS results.</li>
<li>Fangdd Network Group Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/duo#NASDAQ">DUO</a>) fell 23.3% to $0.5710.</li>
<li>WideOpenWest, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wow#NYSE">WOW</a>) fell 21.1% to $2.7290 after the company reported worse-than-expected fourth-quarter financial results and issued guidance.</li>
<li>NaaS Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/naas#NASDAQ">NAAS</a>) fell 20.1% to $1.19 after the company announced a $6 million registered direct offering.</li>
<li>Comtech Telecommunications Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmtl#NASDAQ">CMTL</a>) fell 19% to $4.6599. Comtech named John Ratigan as Interim Chief Executive Officer.</li>
<li>Aterian, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ater#NASDAQ">ATER</a>) tumbled 19% to $0.3783 following quarterly results.</li>
<li>Psyence Biomedical Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pbm#NASDAQ">PBM</a>) fell 17.8% to $1.01.</li>
<li>reAlpha Tech Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aire#NASDAQ">AIRE</a>) fell 16.3% to $1.07 after the company reported EPS for the eight months ended Dec. 31, 2023.</li>
<li>loanDepot, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ldi#NYSE">LDI</a>) fell 15.9% to $2.1350 following weak quarterly results.</li>
<li>Bit Origin Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btog#NASDAQ">BTOG</a>) fell 15.7% to $4.45 after gaining 11% on Tuesday.</li>
<li>Dollar Tree, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dltr#NASDAQ">DLTR</a>) declined 14.5% to $128.00 after the company reported worse-than-expected fourth-quarter financial results and issued first-quarter EPS guidance below estimates.</li>
<li>Rackspace Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rxt#NASDAQ">RXT</a>) dipped 13.3% to $1.9150 after the company issued first-quarter guidance below estimates. The company also announced refinancing transactions.</li>
<li>ZIM Integrated Shipping Services Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/zim#NYSE">ZIM</a>) fell 12.4% to $10.22 following weak quarterly sales.</li>
<li>Neumora Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nmra#NASDAQ">NMRA</a>) declined 12.2% to $15.24.</li>
<li>ECD Automotive Design, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ecda#NASDAQ">ECDA</a>) dipped 10.8% to $1.07 after jumping over 13% on Tuesday.</li>
<li>Solowin Holdings (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swin#NASDAQ">SWIN</a>) fell 8.6% to $26.61.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/24/03/37657561/nvidia-to-rally-around-20-here-are-10-top-analyst-forecasts-for-wednesday"> NVIDIA To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday </a>

Penny Stocks

Small Cap

Intraday Update

ADTH

AIRE

ANNX

ATER

BGNE

BIRD

BTOG

CLOV

CMTL

DLTR

ECDA

EDUC

GXAI

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

HRTX

Kintara Therapeutics, Inc. - Common Stock

KTRA

LICY

LUNA

MINM

MNMD

NAAS

NCNA

NMRA

PIII

PRTG

RXRX

SIGA

SKIN

SMMT

SURG

SWIN

VERI

VJET

Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Nature's Sunshine Products are trading higher after the company reported better-than-expected Q4 adjusted EPS.

DA Davidson analyst Linda Bolton Weiser maintains Natures Sunshine Products (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>) with a Buy and raises the price target from $21.5 to $24.

DA Davidson Maintains Buy on Natures Sunshine Products, Raises Price Target to $24

Nature's Sunshine Products are trading higher after the company reported better-than-expected Q4 adjusted EPS results and issued FY24 net sales guidance.

Press Releases

Nature's Sunshine Products to Present at the 2024 Gateway Conference on September 4th, 2024

Nature's Sunshine Addresses Spanish Fork Manufacturing Facility Incident

Management

Nature's Sunshine Names Kevin Fuller Global Chief Marketing Officer

Nature's Sunshine Sets Third Quarter 2024 Conference Call for Thursday, November 7, 2024, at 5:00 p.m. ET

Nature's Sunshine Reports Third Quarter 2024 Results

Nature's Sunshine Appoints Steven Fasching to Board of Directors

Nature's Sunshine Partners with Cirque Series to Push Peaks 2025-2027

Nature's Sunshine Appoints Katie A. May to Board of Directors

Nature's Sunshine Sets Fourth Quarter and Full Year 2024 Conference Call for Tuesday, March 11, 2025, at 5:00 p.m. ET

Nature's Sunshine Launches First Integrated Brand Platform

DECK

STMP

TSX:STMP

TSX:THNC

AXIL Brands

BellRing Brands

Coty

Big Tree Cloud Holdings Limited - Ordinary Shares

Big Tree Cloud Holdings

Estee Lauder Companies, Inc. (The) Common Stock

Estee Lauder Cos

e.l.f. Beauty

Edgewell Personal Care Company Common Stock

Edgewell Personal Care

FitLife Brands

Herbalife

Honest Co

Interparfums

Kenvue

Lifevantage

Medifast

Natural Health Trends Corp. - Commn Stock

Natural Health Trends

Nu Skin Enterprises

Olaplex Hldgs

Paranovus Entertainment Technology Ltd. - Class A Ordinary Shares

Paranovus Enter

Safety Shot

The Beauty Health Company - Class A Common Stock

Beauty Health

United-Guardian

Unilever

Usana Health Sciences

Waldencast

Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares

Yatsen Holding

Canaccord Genuity

DA Davidson

Comments

Natures Sunshine Products

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL